Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02849067
Other study ID # 14-0598
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 25, 2015
Est. completion date December 30, 2019

Study information

Verified date February 2024
Source Hospital de Clinicas de Porto Alegre
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It is known that laughter can bring benefits in terms of physiological and psychological parameters, in addition to improving the individual's quality of life. However, the literature is still scarce as to the existence of studies investigating the effects of a comedy film specifically in hemodynamics.


Description:

Objective: To evaluate the effect of a comedy film session on the cardiac index, Systemic Vascular Resistance and Vascular Resistance Index Systemic in stable ischemic heart disease patients. Method: Randomized Clinical Trial. Patients will be coming from Ischemic Heart Disease clinic at the Hospital de ClĂ­nicas de Porto Alegre (HCPA), all in regular monitoring.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date December 30, 2019
Est. primary completion date December 30, 2019
Accepts healthy volunteers No
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria: - Ages between 40 and 80 years - Both female and male - Diagnosis of ischemic heart disease by cardiac catheterization , with 50% lesion in at least one epicardial vessel Exclusion Criteria: - Participants enrolled in another Randomized Clinical trial - Autoimmune diseases - Valvulopathy with mechanical or biological cardiac prosthesis - Presence of pacemakers and implantable cardioverter - Left bundle branch block in the electrocardiogram (ECG) of 12 derivations - Severe lung disease - Depression or Bipolar Disorder - Atrial Chronic Fibrillation - Left ventricular dysfunction (ejection fraction <45%) - Active Infection or neoplasia (not Basal cell carcinoma) - Chronic Renal Failure - Illiteracy and inability to understand the consent form

Study Design


Intervention

Other:
Group Treatment
Patients in this group will watch a comedy show that will will not exceed 30 minutes. This group will have until five patients.
Group Control
patients in this group will watch a documentary that will not exceed 30 minutes. This will have until five patients

Locations

Country Name City State
Brazil Hospital De Clínicas de Porto Alegre Porto Alegre Rio Grande Do Sul

Sponsors (1)

Lead Sponsor Collaborator
Hospital de Clinicas de Porto Alegre

Country where clinical trial is conducted

Brazil, 

References & Publications (16)

Bennett M, Lengacher C. Use of complementary therapies in a rural cancer population. Oncol Nurs Forum. 1999 Sep;26(8):1287-94. — View Citation

Bennett MP, Lengacher C. Humor and Laughter May Influence Health: II. Complementary Therapies and Humor in a Clinical Population. Evid Based Complement Alternat Med. 2006 Jun;3(2):187-90. doi: 10.1093/ecam/nel014. Epub 2006 Apr 24. — View Citation

Bennett MP, Lengacher C. Humor and Laughter May Influence Health: III. Laughter and Health Outcomes. Evid Based Complement Alternat Med. 2008 Mar;5(1):37-40. doi: 10.1093/ecam/nem041. — View Citation

Bennett MP, Lengacher CA. Humor and laughter may influence health. I. History and background. Evid Based Complement Alternat Med. 2006 Mar;3(1):61-3. doi: 10.1093/ecam/nek015. Epub 2006 Jan 16. — View Citation

Berk LS, Felten DL, Tan SA, Bittman BB, Westengard J. Modulation of neuroimmune parameters during the eustress of humor-associated mirthful laughter. Altern Ther Health Med. 2001 Mar;7(2):62-72, 74-6. — View Citation

Ishihara S, Nohara R, Makita S, Imai M, Kubo S, Hashimoto T. Immune function and psychological factors in patients with coronary heart disease (I). Jpn Circ J. 1999 Sep;63(9):704-9. doi: 10.1253/jcj.63.704. — View Citation

Lengacher CA, Bennett MP, Kip KE, Keller R, LaVance MS, Smith LS, Cox CE. Frequency of use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum. 2002 Nov-Dec;29(10):1445-52. doi: 10.1188/02.ONF.1445-1452. — View Citation

LEVI L. THE URINARY OUTPUT OF ADRENALIN AND NORADRENALIN DURING PLEASANT AND UNPLEASANT EMOTIONAL STATES. A PRELIMINARY REPORT. Psychosom Med. 1965 Jan-Feb;27:80-5. doi: 10.1097/00006842-196501000-00009. No abstract available. — View Citation

Miller M, Fry WF. The effect of mirthful laughter on the human cardiovascular system. Med Hypotheses. 2009 Nov;73(5):636-9. doi: 10.1016/j.mehy.2009.02.044. Epub 2009 May 27. — View Citation

Miller M, Mangano C, Park Y, Goel R, Plotnick GD, Vogel RA. Impact of cinematic viewing on endothelial function. Heart. 2006 Feb;92(2):261-2. doi: 10.1136/hrt.2005.061424. No abstract available. — View Citation

Mora-Ripoll R. Potential health benefits of simulated laughter: a narrative review of the literature and recommendations for future research. Complement Ther Med. 2011 Jun;19(3):170-7. doi: 10.1016/j.ctim.2011.05.003. Epub 2011 May 25. — View Citation

Overeem S, Taal W, Ocal Gezici E, Lammers GJ, Van Dijk JG. Is motor inhibition during laughter due to emotional or respiratory influences? Psychophysiology. 2004 Mar;41(2):254-8. doi: 10.1111/j.1469-8986.2003.00145.x. — View Citation

Polanczyk CA, Ribeiro JP. Coronary artery disease in Brazil: contemporary management and future perspectives. Heart. 2009 Jun;95(11):870-6. doi: 10.1136/hrt.2008.155853. Epub 2009 Mar 3. — View Citation

Sugawara J, Tarumi T, Tanaka H. Effect of mirthful laughter on vascular function. Am J Cardiol. 2010 Sep 15;106(6):856-9. doi: 10.1016/j.amjcard.2010.05.011. — View Citation

Tan SA, Tan LG, Lukman ST, Berk LS. Humor, as an adjunct therapy in cardiac rehabilitation, attenuates catecholamines and myocardial infarction recurrence. Adv Mind Body Med. 2007 Winter;22(3-4):8-12. — View Citation

Vlachopoulos C, Xaplanteris P, Alexopoulos N, Aznaouridis K, Vasiliadou C, Baou K, Stefanadi E, Stefanadis C. Divergent effects of laughter and mental stress on arterial stiffness and central hemodynamics. Psychosom Med. 2009 May;71(4):446-53. doi: 10.1097/PSY.0b013e318198dcd4. Epub 2009 Feb 27. — View Citation

* Note: There are 16 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Cardiography impedance To assess the volumes and fluid passing through the chest at rest and during the exercise session will be used the Cardiography impedance device PhysioFlow, Enduro model (ManatecBiomedical, France). 28 weeks
Secondary Humor it will be used the Humor Scale of Brunel 28 weeks
See also
  Status Clinical Trial Phase
Completed NCT04097912 - Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
Completed NCT01941355 - Trial of Rehabilitation in Phase 1 After Coronary Artery Bypass Grafting N/A
Active, not recruiting NCT03603210 - Outcomes of Drug Coated Balloon Angioplasty, A UK Real Life Experience From 2009 to 2015
Completed NCT00151658 - Sirolimus Eluting Stents in Complex Coronary Lesions (SCANDSTENT) N/A
Recruiting NCT04193475 - Machine Learning in Quantitative Stress Echocardiography
Completed NCT02290262 - SheppHeartCABG - Phase One Rehabilitation After Coronary Artery Bypass Grafting N/A
Active, not recruiting NCT03736018 - Randomised Controlled Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Coronary Angiography in Bypass Surgery Patients N/A
Recruiting NCT05045118 - The Impact of Structured Patient Education Material (SPEM) in Improving Clinical and Behavioural Outcomes in Home-based Cardiac Rehabilitation Program Participants: A Pilot Study N/A
Completed NCT04901767 - Coronary Artery Endothelial Dysfunction With Drug Coated Balloons
Enrolling by invitation NCT03674255 - Echocardiography: Value and Accuracy at REst and STress
Active, not recruiting NCT03171311 - The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER) N/A
Recruiting NCT04768283 - Cardiac Rehabilitation and Additional Physical Training in Elderly Patients After Acute Coronary Syndrome N/A
Completed NCT02315001 - Liraglutide to Improve corONary Haemodynamics During Exercise streSS Phase 2
Completed NCT01796353 - Effects of a Comprehensive Sexual Rehabilitation Programme in Heart Patients N/A
Recruiting NCT04061525 - Motion and IntraCoronary Ecg Ischemia Development Study (MICE)
Recruiting NCT04674449 - iCorMicA - Stratified Medicine in Angina N/A
Active, not recruiting NCT02623140 - BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX Phase 4
Completed NCT03646097 - Impact of Real-time Angiographic Co-registered OCT on PCI Results - the OPTICO-integration II Study N/A
Completed NCT02053818 - Remifentanil/Sufentanil for CABG+/-AVR Evaluated by Recovery, Cognitive Function, Haemodynamics and Biochemical Markers. Phase 4
Recruiting NCT04014140 - iFR Guided Coronary Artery Bypass Grafting Surgery